Cantitate/Preț
Produs

Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part B: International Review of Cell and Molecular Biology, cartea 390

Carolina Reduzzi, Lorenzo Gerratana, Massimo Cristofanilli
en Limba Engleză Hardback – apr 2025
Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part B, Volume 387 in the International Review of Cell and Molecular Biology series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, including Circulating Tumor Cells in Lung Cancer: integrating stemness and heterogeneity to improve clinical utility, Multi-omic Features and Clustering Phenotypes of Circulating Tumor Cells Associated with Metastasis and Clinical Outcomes, CTCs in CRC: updates, Proteomics and post-translational modification analysis in CTCs, Latest advances of CTC studies in prostate cancer, and Epigenetics and CTCs: new biomarkers and impact on tumor biology.

  • Provides the latest information on cancer research
  • Offers outstanding and original reviews on a range of cancer research topics
  • Serves as an indispensable reference for researchers and students alike
Citește tot Restrânge

Din seria International Review of Cell and Molecular Biology

Preț: 94989 lei

Preț vechi: 133115 lei
-29% Nou

Puncte Express: 1425

Preț estimativ în valută:
18177 19118$ 15188£

Carte nepublicată încă

Doresc să fiu notificat când acest titlu va fi disponibil:

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780443136559
ISBN-10: 0443136556
Pagini: 277
Dimensiuni: 152 x 229 mm
Greutate: 0.45 kg
Editura: ELSEVIER SCIENCE
Seria International Review of Cell and Molecular Biology


Cuprins

1. Circulating Tumor Cells in Lung Cancer: integrating stemness and heterogeneity to improve clinical utility
Giulia Bertolini and Giuseppe Lo Russo
2. Multi-omic Features and Clustering Phenotypes of Circulating Tumor Cells Associated with Metastasis and Clinical Outcomes
Lamiaa El-Shennawy
3. CTCs in CRC: updates
Pashtoon Kasi
4. Proteomics and post-translational modification analysis in CTCs
Huiping Liu
5. Latest advances of CTC studies in prostate cancer
Paraskevi Giannakakou
6. Epigenetics and CTCs: new biomarkers and impact on tumor biology
EVRYKLEIA LIANIDOU and Aliki Ntzifa